Huang Chelsea, Lau Tiffany Wing-See, Smoller Bruce R
Department of Pathology, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.
Department of Pathology, Queen Mary Hospital, Hong Kong, China.
Dermatopathology (Basel). 2024 Jan 18;11(1):26-51. doi: 10.3390/dermatopathology11010005.
Over the past decade, molecular and genomic discoveries have experienced unprecedented growth, fundamentally reshaping our comprehension of melanocytic tumors. This review comprises three main sections. The first part gives an overview of the current genomic landscape of cutaneous melanocytic tumors. The second part provides an update on the associated molecular tests and immunohistochemical stains that are helpful for diagnostic purposes. The third section briefly outlines the diverse molecular pathways now utilized for the classification of cutaneous melanomas. The primary goal of this review is to provide a succinct overview of the molecular pathways involved in melanocytic tumors and demonstrate their practical integration into the realm of diagnostic aids. As the molecular and genomic knowledge base continues to expand, this review hopes to serve as a valuable resource for healthcare professionals, offering insight into the evolving molecular landscape of cutaneous melanocytic tumors and its implications for patient care.
在过去十年中,分子和基因组学的发现经历了前所未有的增长,从根本上重塑了我们对黑素细胞肿瘤的理解。本综述包括三个主要部分。第一部分概述了皮肤黑素细胞肿瘤的当前基因组格局。第二部分介绍了有助于诊断的相关分子检测和免疫组织化学染色的最新情况。第三部分简要概述了目前用于皮肤黑色素瘤分类的各种分子途径。本综述的主要目的是简要概述黑素细胞肿瘤中涉及的分子途径,并展示它们在诊断辅助领域的实际应用。随着分子和基因组知识库的不断扩展,本综述希望成为医疗保健专业人员的宝贵资源,深入了解皮肤黑素细胞肿瘤不断演变的分子格局及其对患者护理的影响。